← Back to headlines
STADA Group Reports Strong Growth Across All Segments in 2025
The STADA Group, which includes Hemofarm, achieved significant growth in 2025 across all three of its segments: specialty pharmaceuticals, consumer health products, and generic medicines.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippine Police Seize P9.75M Diesel, Arrest 9 in Illegal Fuel Transfer Bust
just now
Philippines Signs Two New Petroleum Exploration Contracts in Visayas
just now
Revilla Camp Denies Links to Alleged Ghost Flood Control Project
just now
Philippines Lawmakers Demand Action on Spiking Inflation and Fuel Prices
just now